The Notice Nobody Was Supposed to Notice
Friday, tucked between a scratch-ticket rulebook and a batch of wastewater fines in the back pages of the Texas Register, the Department of State Health Services quietly finished a fight it started five years ago. The notice — 51 TexReg 4597, filed June 25, signed out by DSHS General Counsel Cynthia Hernandez under interim Commissioner Imelda Garcia — reinstates the agency’s 2021 modifications to two entries in the state’s Schedule I: tetrahydrocannabinols and marihuana extract.
If that sounds like administrative housekeeping, understand what the housekeeping accomplishes. Since November of 2021, when Judge Jan Soifer enjoined those definitions in the Sky Marketing case, the entire Texas delta-8 market has operated under the protection of that injunction. On May 1, the Texas Supreme Court took it away, reversing the courts below and siding with the agency. The mandate issued June 5. Friday’s notice is DSHS closing the loop — republishing the definitions exactly as they stood before the injunction, as though the intervening five years were a rounding error.
They were not a rounding error. They were the years this industry was built in.
What the Definitions Actually Say
The reinstated tetrahydrocannabinols entry sweeps in every THC naturally contained in the cannabis plant except one thing: up to 0.3 percent delta-9 in hemp as defined by the Agriculture Code. It then reaches further, to synthetic equivalents, derivatives, and isomers with similar chemical structure and pharmacological activity, and it names the cis and trans variants at multiple positions before adding the kicker — because chemical nomenclature isn’t internationally standardized, compounds of these structures are covered regardless of the numerical designation of atomic positions. That last clause exists for one reason: so nobody can renumber their way out of Schedule I.
The marihuana extract entry does parallel work on the processing side. An extract containing any cannabinoid from any cannabis plant is Schedule I unless it’s derived from hemp and holds under 0.3 percent delta-9 on a dry weight basis — and even then, separated resin, crude or purified, gets no exemption at all.
Read the two entries together and the state’s position is stark. Naturally occurring hemp material and genuinely hemp-derived extracts under the delta-9 threshold remain outside the schedule. Everything else in the family — delta-8, delta-10, THC-O, THCP, HHC, and above all anything converted or synthesized, which as a matter of practical chemistry describes most of the commercial delta-8 ever sold in this state — now sits inside it.
This Is an Enforcement Story, Not a Paperwork Story
Here is the part that needs saying without any softening: this notice will be read by police chiefs, sheriffs, and district attorneys as a permission slip.
Five days before it published, the Senate Health and Human Services Committee staged its interim hearing on THC, and I use the word staged advisedly. The witness table was cast like a morality play: the Allen police chief who ran the North Texas raids, a sheriff, a DA, a traveling anti-THC activist who called the products a weapon of mass destruction, and a committee vice-chair who invoked Nancy Reagan by name, promised a new ban bill for January, and expressed his hope — out loud, on the record — that the state’s new fees would put most of the industry out of business. That was the season premiere of Reefer Madness, Texas edition. Friday’s notice is the prop department handing the cast real ammunition.
An officer who wanted to seize delta-8 in 2023 had to reckon with an injunction and a genuinely murky legal landscape. That officer now has a published Schedule I listing, a Supreme Court opinion behind it, and a political climate in which raids make careers rather than end them. Chief Steve Dye told the committee his labs found seized products testing far above their labels; expect that playbook — seize, test, charge — to travel. There remain real defense arguments about how the schedules interact with the Health and Safety Code’s penalty groups and the hemp statutes, and good lawyers will make them. But an argument made from a defense table is a categorically worse position than an argument never made at all. Retailers and distributors should plan for enforcement and let the lawyers’ arguments be their parachute rather than their plan.
Look at Your Shelves This Week
For anyone holding inventory, the practical assignment is an unsentimental review, done promptly and documented as you go. Walk the warehouse with the definitions in hand. Anything containing or marketed as containing delta-8, delta-10, THC-O, THCP, HHC, or any other THC isomer or analogue belongs in the flagged column. So does anything produced by chemical conversion — delta-8 made from CBD is the textbook case. So does any extract, distillate, or concentrate whose paperwork can’t actually demonstrate hemp origin and sub-threshold delta-9 on a dry weight basis, and any separated resin product, which the exemption pointedly declines to cover. THCA flower and pre-rolls were already casualties of the March 31 total-THC rules and belong on the same list.
For everything flagged, pull the certificates of analysis and read them skeptically: is the lab accredited, does the method measure total THC post-decarboxylation, does the supplier’s story hold up. Where the chemistry is synthetic or the paper trail is thin, quarantine the product and get advice from qualified counsel — and I’ll offer the standing caveat, with affection: I’m a strategist, not a lawyer, and nothing here substitutes for the real thing.
A word, too, for the kratom and mushroom sectors, who may be feeling like spectators: you’re not. Nothing in Friday’s notice touches mitragynine or amanita. But anyone who watched the July 7 hearing noticed its shape — a committee that has learned it can prosecute an entire product category through interim charges, curated witness lists, and administrative reclassification, without ever passing a bill. Hemp is the test case. The machinery being assembled will not be dismantled when it finishes with THC.
The Case We Get to Make
Now the better news, because there is some, and it isn’t decorative.
Prohibitions born of administrative maneuver are less durable than prohibitions born of statute, and this one arrives wearing its weaknesses openly. The Governor vetoed the ban the Legislature passed and asked for regulation instead — that veto message remains the most authoritative statement of Texas policy on this subject. The committee’s own invited expert, Baker Institute drug policy fellow Katharine Neill Harris, told the senators to their faces that they were conflating cannabis with mental illness and homelessness. The sheriff they called, Chambers County’s Brian Hawthorne, testified that what rural Texas actually needs is mental health deputies and telehealth, not a ban. And Senator Charles Perry’s confession that the fee structure is designed to bankrupt registrants — “the cost of doing business is going to get so high that most of them will go out of business, I hope” — is the kind of quote that wins lawsuits and editorial boards alike.
That is raw material, and the interim is when it gets shaped. The committee accepts written testimony, and the record being built right now is the record the 2027 session will legislate from. Businesses that can walk into that fight with clean inventories, accredited lab results, and documented compliance are the living rebuttal to the claim that this industry can’t be regulated because it can’t be trusted. The argument that wins this — the only one that ever has — is that regulation demonstrably works and prohibition demonstrably doesn’t: it forfeits the testing, the labeling, the age-gating, and the tax revenue, and hands the market to people who don’t return phone calls from the state.
The next six months decide whether these products return to Texas shelves as legal, regulated items or disappear into the same gray market the state claims to fear. Get your houses in order, and get your stories on the record — preferably before someone with a badge asks for them.
Sources: Texas Register, Vol. 51, July 10, 2026, at 4597–4604 (TRD-202602610); Sky Marketing Corp. v. Texas Dep’t of State Health Servs. (Tex., opinion May 1, 2026; mandate June 5, 2026); Texas Senate Committee on Health & Human Services interim hearing, July 7, 2026.
